Product Information
GABAPENTIN 400 MG CAPSULE is a generic product labeled by Cipla USA Inc., priced at $0.0410 per EA under NDC 69097081507. Its NADAC has been published 516 times since Aug 10, 2016.
Strength
400 mg/1
Manufacturer
Cipla USA Inc.NDC
69097081507
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA090705On Market Since
6/29/2016
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 400 MG CAPSULE has been published 516 times since Aug 10, 2016, and over the history we have for it it has declined 44.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0410 per EA |
|---|---|
| All-time high | $0.0789 (Jan 16, 2019) |
| All-time low | $0.0396 (Apr 22, 2026) |
| 52-week high | $0.0445 |
| 52-week low | $0.0396 |
| Median price | $0.0633 |
| Average price | $0.0605 |
| Largest weekly change | +23.4% (Aug 21, 2024) |
| Weeks tracked | 516 |
| Tracking since | Aug 10, 2016 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN 400 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 400 MG CAPSULE, manufactured by Cipla USA Inc., is $0.0410 per EA (NDC 69097081507), effective Jun 24, 2026.
How has the price of GABAPENTIN 400 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 400 MG CAPSULE has declined 44.9%. It has been tracked across 516 weekly CMS publications since Aug 10, 2016.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 400 MG CAPSULE?
Since Aug 10, 2016, the NADAC for GABAPENTIN 400 MG CAPSULE has ranged from a low of $0.0396 (Apr 22, 2026) to a high of $0.0789 (Jan 16, 2019), with a median of $0.0633 per EA.
Are there cheaper alternatives to GABAPENTIN 400 MG CAPSULE?
4 NADAC-published products share the same active ingredient, strength, and dosage form as GABAPENTIN 400 MG CAPSULE, but none are currently priced below it.
Who manufactures GABAPENTIN 400 MG CAPSULE?
GABAPENTIN 400 MG CAPSULE (NDC 69097081507) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification